Biogen (BIIB) R&D to Revenue & History | Stock Alarm

Demo Sign up Log In

Biogen · R&D to Revenue

BIIB R&D to Revenue

Latest reported19.92%period endingDec 31, 2025

BIIB FY R&D/Revenue (0.00% → 19.92%)

Latest values, visible window

High-resolution chart · PNG

BIIB r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Biogen R&D to Revenue — Annual fiscal periods
Period ending	R&D to Revenue
Dec 31, 2025	19.9244%
Dec 31, 2024	25.7185%
Dec 31, 2023	27.4777%
Dec 31, 2022	25.5274%
Dec 31, 2021	30.9652%
Dec 31, 2020	33.699%
Dec 31, 2019	19.2692%
Dec 31, 2018	20.1421%
Dec 31, 2017	19.3386%
Dec 31, 2016	17.2359%
Dec 31, 2015	18.6997%
Dec 31, 2014	19.5129%
Dec 31, 2013	21.0005%
Dec 31, 2012	24.9983%
Dec 31, 2011	24.1571%
Dec 31, 2010	26.4735%
Dec 31, 2009	29.3115%
Dec 31, 2008	26.1637%
Dec 31, 2007	29.1701%
Dec 31, 2006	26.7751%
Dec 31, 2005	43.6311%
Dec 31, 2004	42.9793%
Dec 31, 2003	567.5143%
Dec 31, 2002	24.9536%
Dec 31, 2001	30.1787%
Dec 31, 2000	32.7159%
Dec 31, 1999	27.8378%
Dec 31, 1998	31.7848%
Dec 31, 1997	33.5222%
Dec 31, 1996	47.7765%
Dec 31, 1995	57.6488%
Dec 31, 1994	58.3412%
Dec 31, 1993	0%
Dec 31, 1992	0%
Dec 31, 1991	0%
Dec 31, 1990	0%
Dec 31, 1989	0%
Dec 31, 1988	0%
Dec 31, 1987	0%
Dec 31, 1986	0%
Dec 31, 1985	0%

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.